peptide-service
LanePaid brief first for peptide projects.
Best for
Teams that need a clean peptide entry point.
Typical outputs
- Scope call
- Quote
- Next step
Route requests into the right lane, assign one owner, and move to the next step. If it is not a fit, we will say so quickly and keep the handoff clean. Brown Biotech works best when the request arrives with text, files, and signals together, and the same harness can keep working across models.
Each lane is easy to explain, route, and hand off. Submissions return a route preview.
Paid brief first for peptide projects.
Best for
Teams that need a clean peptide entry point.
Typical outputs
Biostatistics for decision-ready outputs.
Best for
Teams that need clearer evidence, faster.
Typical outputs
Discovery support for scope and partnership talks.
Best for
Partners exploring a new research direction.
Typical outputs
Audit-grade transcriptomics pipelines with RO-Crate provenance and LLM-validated gates.
Best for
Teams that need a defensible, reproducible multi-platform omics workflow.
Typical outputs
AI research agent tournament for biotech hypothesis generation.
Best for
Teams that want structured competitive AI research with ranking.
Typical outputs
Keep the entry point small, then expand only when the scope, owner, and next action are clear.
Sample Brief
₩0.3M ~ ₩1M
Preview / scope check
Paid Brief
₩2M ~ ₩8M
Decision-ready research doc
Project
₩8M ~ ₩30M+
Scoped analysis + execution
Retainer
₩3M ~ ₩15M+/mo
Monthly research / ops support
Brown Biotech can package the business pipeline itself as a higher-tier offering for teams that want a reusable workflow with review.
A company-owned pipeline for biotech ops and decision-ready briefs.
Best for
Teams that want a reusable workflow with review.
Define the problem and the outcome.
Assign the lane and first milestone.
Send one clear next step.
Keep the proof visible, keep the outputs reusable, and route serious interest into a clear next step.
Turn the work into decision-ready evidence: scoped memo, citations, and a reusable summary.
Keep selected outputs public so the market can see what Brown Biotech actually ships.
Use talks, reading notes, and partner updates to keep the ecosystem warm and visible.
Route serious inbound interest into a brief, owner, and next action instead of a loose chat.
Brown Biotech should be able to retrieve not just text, but PDFs, screenshots, figures, slides, and audio notes so the brief stays decision-ready.
Decision-ready summaries and scoped requests.
Screenshots, figures, slides, and chart captures.
Meeting clips and spoken context tied back to the brief.
Reusable language only after human review.
Roche's PathAI deal is a good reminder that diagnostics value comes from workflow integration, not just model quality.
Roche × PathAI (2026-05-07)
Diagnostics value now sits in the workflow, not only the model.
Brown Biotech should sell decision-ready routing and review loops, not generic AI.
Nemotron persona team
Small, specialized roles can improve throughput when the handoff is crisp.
The router should output route, owner, approval gate, and next action every time.
A short problem statement and the outcome you want.
We aim to respond within 24 hours.
Yes. We adapt to scope and budget.
Send a short note and we'll route it.